MA37534A1 - Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents

Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37534A1
MA37534A1 MA37534A MA37534A MA37534A1 MA 37534 A1 MA37534 A1 MA 37534A1 MA 37534 A MA37534 A MA 37534A MA 37534 A MA37534 A MA 37534A MA 37534 A1 MA37534 A1 MA 37534A1
Authority
MA
Morocco
Prior art keywords
thyme
essential oil
antibacterial effect
actinomycetemcomitans
aaggregatibacter
Prior art date
Application number
MA37534A
Other languages
French (fr)
Other versions
MA37534B1 (en
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37534A priority Critical patent/MA37534B1/en
Priority to PCT/MA2014/000059 priority patent/WO2016076690A1/en
Publication of MA37534A1 publication Critical patent/MA37534A1/en
Publication of MA37534B1 publication Critical patent/MA37534B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L’application de |’effet antibactérien de |’huile essentielle de thym (thymus vulgaris) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n'a jamais fait l’objet de tests antimicrobiens à base d'huiles essentielles.Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of thyme (thymus vulgaris) of Moroccan origin on a virulent oral bacterial strain; aggregatibacter actinomycetemcomitans clone jp2. This original strain has never been the subject of antimicrobial tests based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.

MA37534A 2014-11-13 2014-11-13 Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans MA37534B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37534A MA37534B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
PCT/MA2014/000059 WO2016076690A1 (en) 2014-11-13 2014-12-31 Pharmacological composition of thyme (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37534A MA37534B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37534A1 true MA37534A1 (en) 2016-06-30
MA37534B1 MA37534B1 (en) 2017-01-31

Family

ID=52684610

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37534A MA37534B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37534B1 (en)
WO (1) WO2016076690A1 (en)

Also Published As

Publication number Publication date
WO2016076690A1 (en) 2016-05-19
MA37534B1 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
CY1122306T1 (en) COMPOSITIONS CONTAINING BAKTHPIAKA STRAIN
AR106768A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES
IL277329A (en) 17beta-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
CO2017013443A2 (en) Compositions comprising bacterial strains of the genus Blautia
BR112018015792A2 (en) oral hygiene compositions and methods of use thereof
NZ725569A (en) Lubricant formulations
CL2020001391A1 (en) Lyophilized formulation of a monoclonal antibody against transthyretin.
MX2019007738A (en) Broadly neutralizing anti-hiv-1 antibodies and methods of use thereof.
ITUA20161822A1 (en) USEFUL COMPOSITIONS IN THE PREVENTION AND / OR IN THE TREATMENT OF ORAL CABLE PATHOLOGIES, OF THE FIRST AIRWAYS AND OF THE ESOFAGO
MA43314A (en) MITIGATED INFLUENZA VECTORS USED FOR THE PROPHYLAXIS AND / OR TREATMENT OF INFECTIOUS DISEASES AS WELL AS FOR THE TREATMENT OF ONCOLOGICAL DISEASES
MX2021006977A (en) Anellosomes and methods of use.
EA202091259A1 (en) METHOD FOR OBTAINING OPICAPONE AND ITS INTERMEDIATES
BR102019017062A8 (en) TOPICAL COMPOSITIONS INCLUDING PICHIA ANOMALA AND RETINOL
AR111099A1 (en) USE OF A SERUM FOR CLOTHING WASHING
MA37534B1 (en) Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
FR3097125B1 (en) Coloring composition comprising a combination of two plant extracts of Lawsonia inermis
MA37532B1 (en) Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37533B1 (en) Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37530A1 (en) Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans
BR112022010879A2 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF EDEMA REFRACTORY TO ORAL DIURETICS
BR102019017344A8 (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE
MA37529A1 (en) Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans.
MA37531B1 (en) Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
CL2018002949A1 (en) Compositions for oral care.
MA49960A (en) HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME